Obinutuzumab (GA101) is a humanized IgG1 monoclonal antibody of Type II targeting CD20, currently under development for the treatment of non-Hodgkin lymphoma. This therapeutic antibody is designed to bind specifically to the CD20 antigen expressed on the surface of B cells, facilitating targeted immunotherapy with potential applications in oncological research and clinical practice.
Obinutuzumab (GA101) is a humanized IgG1 monoclonal antibody of Type II targeting CD20, currently under development for the treatment of non-Hodgkin lymphoma. This therapeutic antibody is designed to bind specifically to the CD20 antigen expressed on the surface of B cells, facilitating targeted immunotherapy with potential applications in oncological research and clinical practice.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
